Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteosarcoma in young children.

H Kozakewich1, A R Perez-Atayde, A M Goorin

  • 1Department of Pathology, Children's Hospital, Boston, MA 02115.

Cancer
|February 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The pre-rRNA processing factor DEF is rate limiting for the pathogenesis of MYCN-driven neuroblastoma.

Oncogene·2017
Same author

Diagnostic and surgical challenge: middle ear dermoid cyst in 12 month old with branchio-oto-renal syndrome and multiple middle-ear congenital anomalies.

International journal of pediatric otorhinolaryngology·2011
Same author

Comparative analysis of D2-40 and LYVE-1 immunostaining in lymphatic malformations.

Lymphology·2008
Same author

Vascular tumors of the heart in infants and children: case series and review of the literature.

Pediatric cardiology·2004
Same author

Cardiac, aortic, and pulmonary arteriopathy in HIV-infected children: the Prospective P2C2 HIV Multicenter Study.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·2004
Same author

[Skeletal vascular lesions in childhood and adolescence].

Der Pathologe·2004
Same journal

Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

Cancer·2026
Same journal

Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

Cancer·2026
Same journal

EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

Cancer·2026
Same journal

Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

Cancer·2026
Same journal

Most older patients with advanced cancer prioritize QOL over extending survival: A secondary analysis of the GAP70+ trial found that among adults aged 70 and older with advanced, noncurable cancer, nearly three-quarters prioritized maintaining QOL.

Cancer·2026
Same journal

Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer.

Cancer·2026
See all related articles

Pediatric osteosarcoma survival improved significantly after 1972 due to effective chemotherapy. Combining surgery with chemotherapy offers the best chance for long-term survival in children with osteosarcoma.

Area of Science:

  • Pediatric Oncology
  • Orthopedic Oncology
  • Cancer Research

Background:

  • Osteosarcoma is a rare bone cancer primarily affecting children and adolescents.
  • Treatment advancements have historically impacted survival rates for pediatric osteosarcoma.

Purpose of the Study:

  • To evaluate the clinicopathologic features and outcomes of osteosarcoma in children under 16.
  • To assess the impact of chemotherapy introduction on pediatric osteosarcoma survival.

Main Methods:

  • Retrospective review of 12 pediatric osteosarcoma cases treated over 70 years.
  • Comparison of survival rates before and after 1972, correlating with chemotherapy introduction.

Main Results:

  • Only 1 of 6 children treated before 1972 survived long-term.

Related Experiment Videos

  • 4 of 6 children (67%) treated after 1972 achieved disease-free survival with an average follow-up of 8.8 years.
  • The introduction of high-dose methotrexate and leucovorin rescue chemotherapy in 1972 marked a significant improvement.

    • Conclusions:

    • Osteosarcoma in young children shares similar features and behavior with older patients.
    • Aggressive chemotherapy combined with wide surgical resection or amputation is crucial for improving long-term survival in pediatric osteosarcoma.